In addition, SeCys plays a role in blocking the tumor cell cycle 55 and promoting the activation of the p38 MAPK, JNK, and ERK signaling pathways while inhibiting AKT activity, inducing DNA damage in tumor cells 56, 57. This evidence concerns the gene AKT1 and neoplasm.